-
1
-
-
84889894703
-
-
May 10, update
-
National Cancer Institute: Cancer Drug Information: Cisplatin, May 10, 2011 update. http://www.cancer.gov/cancertopics/druginfo/cisplatin
-
(2011)
Cancer Drug Information: Cisplatin
-
-
-
2
-
-
33644848462
-
Ototoxicity in children receiving platinum chemotherapy: Underestimating a commonly occurring toxicity that may influence academic and social development
-
DOI 10.1200/JCO.2004.00.5355
-
Knight KR, Kraemer DF, Neuwelt EA: Ototoxicity in children receiving platinum chemotherapy: Underestimating a commonly occurring toxicity that may influence academic and social development. J Clin Oncol 23:8588-8596, 2005 (Pubitemid 46211500)
-
(2005)
Journal of Clinical Oncology
, vol.23
, Issue.34
, pp. 8588-8596
-
-
Knight, K.R.G.1
Kraemer, D.F.2
Neuwelt, E.A.3
-
3
-
-
34247110863
-
Early changes in auditory function as a result of platinum chemotherapy: Use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions
-
DOI 10.1200/JCO.2006.07.9723
-
Knight KR, Kraemer DF, Winter C, et al: Early changes in auditory function as a result of platinum chemotherapy: Use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions. J Clin Oncol 25:1190-1195, 2007 (Pubitemid 46640564)
-
(2007)
Journal of Clinical Oncology
, vol.25
, Issue.10
, pp. 1190-1195
-
-
Knight, K.R.1
Kraemer, D.P.2
Winter, C.3
Neuwelt, E.A.4
-
4
-
-
0034900079
-
Delayed sodium thiosulfate as an otoprotectant against carboplatin-induced hearing loss in patients with malignant brain tumors
-
Doolittle ND, Muldoon LL, Brummett RE, et al: Delayed sodium thiosulfate as an otoprotectant against carboplatin-induced hearing loss in patients with malignant brain tumors. Clin Cancer Res 7:493-500, 2001 (Pubitemid 32707970)
-
(2001)
Clinical Cancer Research
, vol.7
, Issue.3
, pp. 493-500
-
-
Doolittle, N.D.1
Muldoon, L.L.2
Brummett, R.E.3
Tyson, R.M.4
Lacy, C.5
Bubalo, J.S.6
Kraemer, D.F.7
Heinrich, M.C.8
Henry, J.A.9
Neuwelt, E.A.10
-
5
-
-
14444287268
-
First evidence of otoprotection against carboplatin-induced hearing loss with a two-compartment system in patients with central nervous system malignancy using sodium thiosulfate
-
Neuwelt EA, Brummett RE, Doolittle ND, et al: First evidence of otoprotection against carboplatin-induced hearing loss with a two-compartment system in patients with central nervous system malignancy using sodium thiosulfate. J Pharmacol Exp Ther 286: 77-84, 1998 (Pubitemid 28317976)
-
(1998)
Journal of Pharmacology and Experimental Therapeutics
, vol.286
, Issue.1
, pp. 77-84
-
-
Neuwelt, E.A.1
Brummett, R.E.2
Doolittle, N.D.3
Muldoon, L.L.4
Kroll, R.A.5
Pagel, M.A.6
Dojan, R.7
Church, V.8
Remsen, L.G.9
Bubalo, J.S.10
-
6
-
-
0023686138
-
Ototoxicity of high-dose cis-platinum in children
-
Brock P, Pritchard J, Bellman S, et al: Ototoxicity of high-dose cis-platinum in children. Med Pediatr Oncol 16:368-369, 1988
-
(1988)
Med Pediatr Oncol
, vol.16
, pp. 368-369
-
-
Brock, P.1
Pritchard, J.2
Bellman, S.3
-
7
-
-
0025864140
-
Cisplatin ototoxicity in children: A practical grading system
-
Brock PR, Bellman SC, Yeomans EC, et al: Cisplatin ototoxicity in children: A practical grading system. Med Pediatr Oncol 19:295-300, 1991
-
(1991)
Med Pediatr Oncol
, vol.19
, pp. 295-300
-
-
Brock, P.R.1
Bellman, S.C.2
Yeomans, E.C.3
-
9
-
-
0024525184
-
Enhanced cis-platinum ototoxicity in children with brain tumours who have received simultaneous or prior cranial irradiation
-
Walker DA, Pillow J, Waters KD, et al: Enhanced cis-platinum ototoxicity in children with brain tumours who have received simultaneous or prior cranial irradiation. Med Pediatr Oncol 17:48-52, 1989
-
(1989)
Med Pediatr Oncol
, vol.17
, pp. 48-52
-
-
Walker, D.A.1
Pillow, J.2
Waters, K.D.3
-
10
-
-
52449096175
-
Re: Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy?
-
author reply 1334-1335
-
Bhutani M, Pathak AK: Re: Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy? J Natl Cancer Inst 100:1334, 2008; author reply 1334-1335
-
(2008)
J Natl Cancer Inst
, vol.100
, pp. 1334
-
-
Bhutani, M.1
Pathak, A.K.2
-
11
-
-
44949179401
-
Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy?
-
DOI 10.1093/jnci/djn148
-
Lawenda BD, Kelly KM, Ladas EJ, et al: Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy? J Natl Cancer Inst 100:773-783, 2008 (Pubitemid 351809666)
-
(2008)
Journal of the National Cancer Institute
, vol.100
, Issue.11
, pp. 773-783
-
-
Lawenda, B.D.1
Kelly, K.M.2
Ladas, E.J.3
Sagar, S.M.4
Vickers, A.5
Blumberg, J.B.6
-
12
-
-
59049105617
-
Re: Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy?
-
author reply 125-126
-
Block K, Koch A, Mead M, et al: Re: Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy? J Natl Cancer Inst 101:124-125, 2009; author reply 125-126
-
(2009)
J Natl Cancer Inst
, vol.101
, pp. 124-125
-
-
Block, K.1
Koch, A.2
Mead, M.3
-
13
-
-
2142788844
-
Protection against cisplatin-induced ototoxicity by N-acetylcysteine in a rat model
-
DOI 10.1016/j.heares.2004.02.007, PII S0378595504000814
-
Thomas Dickey D, Muldoon LL, Kraemer DF, et al: Protection against cisplatin-induced ototoxicity by N-acetylcysteine in a rat model. Hear Res 193: 25-30, 2004 (Pubitemid 38813422)
-
(2004)
Hearing Research
, vol.193
, Issue.1-2
, pp. 25-30
-
-
Dickey, D.T.1
Muldoon, L.L.2
Kraemer, D.F.3
Neuwelt, E.A.4
-
14
-
-
23944447422
-
Protection against cisplatin-induced toxicities by N-acetylcysteine and sodium thiosulfate as assessed at the molecular, cellular, and in vivo levels
-
DOI 10.1124/jpet.105.087601
-
Dickey DT, Wu YJ, Muldoon LL, et al: Protection against cisplatin-induced toxicities by N-acetylcysteine and sodium thiosulfate as assessed at the molecular, cellular, and in vivo levels. J Pharmacol Exp Ther 314: 1052-1058, 2005 (Pubitemid 41205968)
-
(2005)
Journal of Pharmacology and Experimental Therapeutics
, vol.314
, Issue.3
, pp. 1052-1058
-
-
Dickey, D.T.1
Wu, Y.J.2
Muldoon, L.L.3
Neuwelt, E.A.4
-
15
-
-
0025946498
-
Dose-dependent inner ear changes after i.v. administration of cisplatin
-
Laurell G, Bagger-Sjöbäck D: Dose-dependent inner ear changes after i.v. administration of cisplatin. J Otolaryngol 20:158-167, 1991
-
(1991)
J Otolaryngol
, vol.20
, pp. 158-167
-
-
Laurell, G.1
Bagger-Sjöbäck, D.2
-
16
-
-
0030848637
-
Quantitative relationship of carboplatin dose to magnitude of inner and outer hair cell loss and the reduction in distortion product otoacoustic emission amplitude in chinchillas
-
DOI 10.1016/S0378-5955(97)00123-8, PII S0378595597001238
-
Hofstetter P, Ding D, Powers N, et al: Quantitative relationship of carboplatin dose to magnitude of inner and outer hair cell loss and the reduction in distortion product otoacoustic emission amplitude in chinchillas. Hear Res 112:199-215, 1997 (Pubitemid 27435996)
-
(1997)
Hearing Research
, vol.112
, Issue.1-2
, pp. 199-215
-
-
Hofstetter, P.1
Ding, D.2
Powers, N.3
Salvi, R.J.4
-
17
-
-
0030063767
-
In vitro and animal studies of sodium thiosulfate as a potential chemoprotectant against carboplatin-induced ototoxicity
-
Neuwelt EA, Brummett RE, Remsen LG, et al: In vitro and animal studies of sodium thiosulfate as a potential chemoprotectant against carboplatin-induced ototoxicity. Cancer Res 56: 706-709, 1996 (Pubitemid 26055456)
-
(1996)
Cancer Research
, vol.56
, Issue.4
, pp. 706-709
-
-
Neuwelt, E.A.1
Brummett, R.E.2
Remsen, L.G.3
Kroll, R.A.4
Pagel, M.A.5
McCormick, C.I.6
Guitjens, S.7
Muldoon, L.L.8
-
18
-
-
0021930924
-
Ototoxicity of low- and moderate-dose cisplatin
-
DOI 10.1002/1097-0142(19851015)56:8<1934::AID-CNCR2820560807>3.0. CO;2-F
-
Schaefer SD, Post JD, Close LG, et al: Ototoxicity of low- and moderate-dose cisplatin. Cancer 56:1934-1939, 1985 (Pubitemid 15240862)
-
(1985)
Cancer
, vol.56
, Issue.8
, pp. 1934-1939
-
-
Schaefer, S.D.1
Post, J.D.2
Close, L.G.3
Wright, C.G.4
-
19
-
-
0345256652
-
Cisplatin: Mode of cytotoxic action and molecular basis of resistance
-
DOI 10.1038/sj.onc.1206933, Drug Resistance
-
Siddik ZH: Cisplatin: Mode of cytotoxic action and molecular basis of resistance. Oncogene 22:7265-7279, 2003 (Pubitemid 37487159)
-
(2003)
Oncogene
, vol.22
, Issue.47 REV. ISS. 6
, pp. 7265-7279
-
-
Siddik, Z.H.1
-
20
-
-
70149105274
-
Using acetaminophen's toxicity mechanism to enhance cisplatin efficacy in hepatocarcinoma and hepatoblastoma cell lines
-
Neuwelt AJ, Wu YJ, Knap N, et al: Using acetaminophen's toxicity mechanism to enhance cisplatin efficacy in hepatocarcinoma and hepatoblastoma cell lines. Neoplasia 11:1003-1011, 2009
-
(2009)
Neoplasia
, vol.11
, pp. 1003-1011
-
-
Neuwelt, A.J.1
Wu, Y.J.2
Knap, N.3
-
22
-
-
34547098814
-
Apoptosis by cisplatin requires p53 mediated p38alpha MAPK activation through ROS generation
-
DOI 10.1007/s10495-007-0082-8
-
Bragado P, Armesilla A, Silva A, et al: Apoptosis by cisplatin requires p53 mediated p38alpha MAPK activation through ROS generation. Apoptosis 12:1733-1742, 2007 (Pubitemid 47106882)
-
(2007)
Apoptosis
, vol.12
, Issue.9
, pp. 1733-1742
-
-
Bragado, P.1
Armesilla, A.2
Silva, A.3
Porras, A.4
-
23
-
-
36448938351
-
The anticancer drug cisplatin induces an intrinsic apoptotic pathway inside the inner ear
-
García-Berrocal JR, Nevado J, Ramírez-Camach R, et al: The anticancer drug cisplatin induces an intrinsic apoptotic pathway inside the inner ear. Br J Pharmacol 152:1012-1020, 2007
-
(2007)
Br J Pharmacol
, vol.152
, pp. 1012-1020
-
-
García-Berrocal, J.R.1
Nevado, J.2
Ramírez-Camach, R.3
-
24
-
-
0032479907
-
Caspase inhibitors prevent cisplatin-induced apoptosis of auditory sensory cells
-
Liu W, Staecker H, Stupak H, et al: Caspase inhibitors prevent cisplatin-induced apoptosis of auditory sensory cells. Neuroreport 9:2609-2614, 1998 (Pubitemid 28387158)
-
(1998)
NeuroReport
, vol.9
, Issue.11
, pp. 2609-2614
-
-
Liu, W.1
Staecker, H.2
Stupak, H.3
Malgrange, B.4
Lefebvre, P.5
Van De, W.T.R.6
-
25
-
-
0036812470
-
Caspase activation in hair cells of the mouse utricle exposed to neomycin
-
Cunningham LL, Cheng AG, Rubel EW: Caspase activation in hair cells of the mouse utricle exposed to neomycin. J Neurosci 22:8532-8540, 2002 (Pubitemid 35387593)
-
(2002)
Journal of Neuroscience
, vol.22
, Issue.19
, pp. 8532-8540
-
-
Cunningham, L.L.1
Cheng, A.G.2
Rubel, E.W.3
-
26
-
-
0037083450
-
Inhibition of caspases prevents ototoxic and ongoing hair cell death
-
Matsui JI, Ogilvie JM, Warchol ME: Inhibition of caspases prevents ototoxic and ongoing hair cell death. J Neurosci 22:1218-1227, 2002 (Pubitemid 34163723)
-
(2002)
Journal of Neuroscience
, vol.22
, Issue.4
, pp. 1218-1227
-
-
Matsui, J.I.1
Ogilvie, J.M.2
Warchol, M.E.3
-
28
-
-
12644293785
-
Use of organotypic cultures of Corti's organ to study the protective effects of antioxidant molecules on cisplatin-induced damage of auditory hair cells
-
Kopke RD, Liu W, Gabaizadeh R, et al: Use of organotypic cultures of Corti's organ to study the protective effects of antioxidant molecules on cisplatin-induced damage of auditory hair cells. Am J Otol 18:559-571, 1997 (Pubitemid 27428342)
-
(1997)
American Journal of Otology
, vol.18
, Issue.5
, pp. 559-571
-
-
Kopke, R.D.1
Liu, W.2
Gabaizadeh, R.3
Jacono, A.4
Feghali, J.5
Spray, D.6
Garcia, P.7
Steinman, H.8
Malgrange, B.9
Ruben, R.J.10
Rybak, L.11
Van De, W.T.R.12
-
29
-
-
0035397409
-
Cisplatin ototoxicity: Involvement of iron and enhanced formation of superoxide anion radicals
-
DOI 10.1006/taap.2001.9171
-
Dehne N, Lautermann J, Petrat F, et al: Cisplatin ototoxicity: Involvement of iron and enhanced formation of superoxide anion radicals. Toxicol Appl Pharmacol 174:27-34, 2001 (Pubitemid 32635003)
-
(2001)
Toxicology and Applied Pharmacology
, vol.174
, Issue.1
, pp. 27-34
-
-
Dehne, N.1
Lautermann, J.2
Petrat, F.3
Rauen, U.4
De Groot, H.5
-
30
-
-
8544273753
-
NOX3, a superoxide-generating NADPH oxidase of the inner ear
-
DOI 10.1074/jbc.M403046200
-
Bánfi B, Malgrange B, Knisz J, et al: NOX3, a superoxide- generating NADPH oxidase of the inner ear. J Biol Chem 279:46065-46072, 2004 (Pubitemid 39491600)
-
(2004)
Journal of Biological Chemistry
, vol.279
, Issue.44
, pp. 46065-46072
-
-
Banfi, B.1
Malgrange, B.2
Knisz, J.3
Steger, K.4
Dubois-Dauphin, M.5
Krause, K.-H.6
-
31
-
-
33947212468
-
Mechanisms of cisplatin-induced ototoxicity and prevention
-
DOI 10.1016/j.heares.2006.09.015, PII S0378595506002723, Pharmacological Strategies for Prevention and Treatment of Hearing Loss and Tinnitus
-
Rybak LP, Whitworth CA, Mukherjea D, et al: Mechanisms of cisplatin-induced ototoxicity and prevention. Hear Res 226:157-167, 2007 (Pubitemid 46428033)
-
(2007)
Hearing Research
, vol.226
, Issue.1-2
, pp. 157-167
-
-
Rybak, L.P.1
Whitworth, C.A.2
Mukherjea, D.3
Ramkumar, V.4
-
32
-
-
0033916023
-
Effect of protective agents against cisplatin ototoxicity
-
Rybak LP, Husain K, Morris C, et al: Effect of protective agents against cisplatin ototoxicity. Am J Otol 21:513-520, 2000 (Pubitemid 30432460)
-
(2000)
American Journal of Otology
, vol.21
, Issue.4
, pp. 513-520
-
-
Rybak, L.P.1
Husain, K.2
Morris, C.3
Whitworth, C.4
Somani, S.5
-
33
-
-
0042967906
-
Cisplatin ototoxicity in the guinea pig: Vestibular and cochlear damage
-
DOI 10.1016/S0378-5955(03)00142-4
-
Sergi B, Ferraresi A, Troiani D, et al: Cisplatin ototoxicity in the guinea pig: Vestibular and cochlear damage. Hear Res 182:56-64, 2003 (Pubitemid 37013284)
-
(2003)
Hearing Research
, vol.182
, Issue.1-2
, pp. 56-64
-
-
Sergi, B.1
Ferraresi, A.2
Troiani, D.3
Paludetti, G.4
Fetoni, A.R.5
-
34
-
-
34147137757
-
Effects of a single high dose of cisplatin on the melanocytes of the stria vascularis in the guinea pig
-
DOI 10.1159/000099020
-
Laurell G, Ekborn A, Viberg A, et al: Effects of a single high dose of cisplatin on the melanocytes of the stria vascularis in the guinea pig. Audiol Neurootol 12:170-178, 2007 (Pubitemid 46558925)
-
(2007)
Audiology and Neurotology
, vol.12
, Issue.3
, pp. 170-178
-
-
Laurell, G.1
Ekborn, A.2
Viberg, A.3
Canlon, B.4
-
35
-
-
77955771808
-
Competitive antagonism of fluorescent gentamicin uptake in the cochlea
-
Wang Q, Kachelmeier A, Steyger PS: Competitive antagonism of fluorescent gentamicin uptake in the cochlea. Hearing Res 268:250-259, 2010
-
(2010)
Hearing Res
, vol.268
, pp. 250-259
-
-
Wang, Q.1
Kachelmeier, A.2
Steyger, P.S.3
-
36
-
-
0019484069
-
Pharmacokinetic study of cerebrospinal fluid penetration of cis-diamminedichloroplatinum (II)
-
DOI 10.1007/BF00434394
-
Gormley PE, Gangji D, Wood JH, et al: Pharmacokinetic study of cerebrospinal fluid penetration of cis-diamminedichloroplatinum (II). Cancer Chemother Pharmacol 5:257-260, 1981 (Pubitemid 11127420)
-
(1981)
Cancer Chemotherapy and Pharmacology
, vol.5
, Issue.4
, pp. 257-260
-
-
Gormley, P.E.1
Gangji, D.2
Wood, J.H.3
Poplack, D.G.4
-
37
-
-
14644394281
-
Plasma and cerebrospinal fluid pharmacokinetics of intravenous oxaliplatin, cisplatin, and carboplatin in nonhuman primates
-
Jacobs SS, Fox E, Dennie C, et al: Plasma and cerebrospinal fluid pharmacokinetics of intravenous oxaliplatin, cisplatin, and carboplatin in nonhuman primates. Clin Cancer Res 11:1669-1674, 2005
-
(2005)
Clin Cancer Res
, vol.11
, pp. 1669-1674
-
-
Jacobs, S.S.1
Fox, E.2
Dennie, C.3
-
38
-
-
18044362704
-
Immunohistochemical detection of platinated DNA in the cochlea of cisplatin-treated guinea pigs
-
van Ruijven MW, de Groot JC, Hendriksen F, et al: Immunohistochemical detection of platinated DNA in the cochlea of cisplatin-treated guinea pigs. Hear Res 203:112-121, 2005
-
(2005)
Hear Res
, vol.203
, pp. 112-121
-
-
Van Ruijven, M.W.1
De Groot, J.C.2
Hendriksen, F.3
-
39
-
-
33745278586
-
High accumulation of platinum-DNA adducts in strial marginal cells of the cochlea is an early event in cisplatin but not carboplatin ototoxicity
-
Thomas JP, Lautermann J, Liedert B, et al: High accumulation of platinum-DNA adducts in strial marginal cells of the cochlea is an early event in cisplatin but not carboplatin ototoxicity. Mol Pharmacol 70:23-29, 2006
-
(2006)
Mol Pharmacol
, vol.70
, pp. 23-29
-
-
Thomas, J.P.1
Lautermann, J.2
Liedert, B.3
-
40
-
-
44849099528
-
Blood-neural barrier: Its diversity and coordinated cell-to-cell communication
-
Choi YK, Kim KW: Blood-neural barrier: Its diversity and coordinated cell-to-cell communication. BMB Rep 41:345-352, 2008
-
(2008)
BMB Rep
, vol.41
, pp. 345-352
-
-
Choi, Y.K.1
Kim, K.W.2
-
41
-
-
37149034911
-
Strategies to advance translational research into brain barriers
-
DOI 10.1016/S1474-4422(07)70326-5, PII S1474442207703265
-
Neuwelt E, Abbott NJ, Abrey L, et al: Strategies to advance translational research into brain barriers. Lancet Neurol 7:84-96, 2008 (Pubitemid 350258701)
-
(2008)
The Lancet Neurology
, vol.7
, Issue.1
, pp. 84-96
-
-
Neuwelt, E.1
Abbott, N.J.2
Abrey, L.3
Banks, W.A.4
Blakley, B.5
Davis, T.6
Engelhardt, B.7
Grammas, P.8
Nedergaard, M.9
Nutt, J.10
Pardridge, W.11
Rosenberg, G.A.12
Smith, Q.13
Drewes, L.R.14
-
42
-
-
70649113052
-
Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy
-
Ross CJ, Katzov-Eckert H, Dubé MP, et al: Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy. Nat Genet 41:1345-1349, 2009
-
(2009)
Nat Genet
, vol.41
, pp. 1345-1349
-
-
Ross, C.J.1
Katzov-Eckert, H.2
Dubé, M.P.3
-
43
-
-
33646246978
-
Effect of concurrent medications on cisplatin-induced nephrotoxicity in patients with head and neck cancer
-
Shord SS, Thompson DM, Krempl GA, et al: Effect of concurrent medications on cisplatin-induced nephrotoxicity in patients with head and neck cancer. Anticancer Drugs 17:207-215, 2006
-
(2006)
Anticancer Drugs
, vol.17
, pp. 207-215
-
-
Shord, S.S.1
Thompson, D.M.2
Krempl, G.A.3
-
44
-
-
0033960541
-
Cisplatin-induced hearing loss: Influence of the mode of drug administration in the guinea pig
-
DOI 10.1016/S0378-5955(99)00190-2, PII S0378595599001902
-
Ekborn A, Laurell G, Andersson A, et al: Cisplatin-induced hearing loss: Influence of the mode of drug administration in the guinea pig. Hear Res 140:38-44, 2000 (Pubitemid 30079633)
-
(2000)
Hearing Research
, vol.140
, Issue.1-2
, pp. 38-44
-
-
Ekborn, A.1
Laurell, G.2
Andersson, A.3
Wallin, I.4
Eksborg, S.5
Ehrsson, H.6
-
45
-
-
0025844777
-
Partial reversibility of cisplatin nephrotoxicity in children
-
Brock PR, Koliouskas DE, Barratt TM, et al: Partial reversibility of cisplatin nephrotoxicity in children. J Pediatr 118:531-534, 1991
-
(1991)
J Pediatr
, vol.118
, pp. 531-534
-
-
Brock, P.R.1
Koliouskas, D.E.2
Barratt, T.M.3
-
46
-
-
38349168706
-
Megalin genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin
-
Riedemann L, Lanvers C, Deuster D, et al: Megalin genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin. Pharmacogenomics J 8:23-28, 2008
-
(2008)
Pharmacogenomics J
, vol.8
, pp. 23-28
-
-
Riedemann, L.1
Lanvers, C.2
Deuster, D.3
-
47
-
-
0033790607
-
Glutathione S-transferase genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin
-
Peters U, Preisler-Adams S, Hebeisen A, et al: Glutathione S-transferase genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin. Anticancer Drugs 11:639-643, 2000
-
(2000)
Anticancer Drugs
, vol.11
, pp. 639-643
-
-
Peters, U.1
Preisler-Adams, S.2
Hebeisen, A.3
-
48
-
-
40949130371
-
Platinum resistance: The role of DNA repair pathways
-
DOI 10.1158/1078-0432.CCR-07-2238
-
Martin LP, Hamilton TC, Schilder RJ: Platinum resistance: The role of DNA repair pathways. Clin Cancer Res 14:1291-1295, 2008 (Pubitemid 351413906)
-
(2008)
Clinical Cancer Research
, vol.14
, Issue.5
, pp. 1291-1295
-
-
Martin, L.P.1
Hamilton, T.C.2
Schilder, R.J.3
-
49
-
-
4143051317
-
Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy
-
DOI 10.1158/1078-0432.CCR-04-0247
-
Zhou W, Gurubhagavatula S, Liu G, et al: Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced nonsmall cell lung cancer patients treated with platinum-based chemotherapy. Clin Cancer Res 10: 4939-4943, 2004 (Pubitemid 39099767)
-
(2004)
Clinical Cancer Research
, vol.10
, Issue.15
, pp. 4939-4943
-
-
Zhou, W.1
Gurubhagavatula, S.2
Liu, G.3
Park, S.4
Neuberg, D.S.5
Wain, J.C.6
Lynch, T.J.7
Su, L.8
Christiani, D.C.9
-
50
-
-
20044368468
-
Polymorphisms in ERCC1 and grade 3 or 4 toxicity in non-small cell lung cancer patients
-
DOI 10.1158/1078-0432.CCR-04-1953
-
Suk R, Gurubhagavatula S, Park S, et al: Polymorphisms in ERCC1 and grade 3 or 4 toxicity in non-small cell lung cancer patients. Clin Cancer Res 11:1534-1538, 2005 (Pubitemid 40315237)
-
(2005)
Clinical Cancer Research
, vol.11
, Issue.4
, pp. 1534-1538
-
-
Suk, R.1
Gurubhagavatula, S.2
Park, S.3
Zhou, W.4
Su, L.5
Lynch, T.J.6
Wain, J.C.7
Neuberg, D.8
Liu, G.9
Christiani, D.C.10
-
51
-
-
0027226069
-
Mitochondrial ribosomal RNA mutation associated with both antibiotic- induced and non-syndromic deafness
-
DOI 10.1038/ng0793-289
-
Prezant TR, Agapian JV, Bohlman MC, et al: Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nat Genet 4:289-294, 1993 (Pubitemid 23205179)
-
(1993)
Nature Genetics
, vol.4
, Issue.3
, pp. 289-294
-
-
Prezant, T.R.1
Agapian, J.V.2
Bohlman, M.C.3
Bu, X.4
Oztas, S.5
Qiu, W.-Q.6
Arnos, K.S.7
Cortopassi, G.A.8
Jaber, L.9
Rotter, J.I.10
Shohat, M.11
Fischel-Ghodsian, N.12
-
52
-
-
0033361927
-
The A1555G mutation in the 12S rRNA gene of human mtDNA: Recurrent origins and founder events in families affected by sensorineural deafness
-
DOI 10.1086/302642
-
Torroni A, Cruciani F, Rengo C, et al: The A1555G mutation in the 12S rRNA gene of human mtDNA: Recurrent origins and founder events in families affected by sensorineural deafness. Am J Hum Genet 65:1349-1358, 1999 (Pubitemid 30460385)
-
(1999)
American Journal of Human Genetics
, vol.65
, Issue.5
, pp. 1349-1358
-
-
Torroni, A.1
Cruciani, F.2
Rengo, C.3
Sellitto, D.4
Lopez-Bigas, N.5
Rabionet, R.6
Govea, N.7
Lopez, D.M.A.8
Sarduy, M.9
Romero, L.10
Villamar, M.11
Del, C.I.12
Moreno, F.13
Estivill, X.14
Scozzari, R.15
-
53
-
-
13044279515
-
Inherited susceptibility to aminoglycoside ototoxicity: Genetic heterogeneity and clinical implications
-
DOI 10.1016/S0196-0709(99)90062-5
-
Casano RA, Johnson DF, Bykhovskaya Y, et al: Inherited susceptibility to aminoglycoside ototoxicity: Genetic heterogeneity and clinical implications. Am J Otolaryngol 20:151-156, 1999 (Pubitemid 29196560)
-
(1999)
American Journal of Otolaryngology - Head and Neck Medicine and Surgery
, vol.20
, Issue.3
, pp. 151-156
-
-
Casano, R.A.M.S.1
Johnson, D.F.2
Bykhovskaya, Y.3
Torricelli, F.4
Bigozzi, M.5
Fischel-Ghodsian, N.6
-
54
-
-
70349678400
-
Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients
-
Caronia D, Patiño-García A, Milne RL, et al: Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients. Pharmacogenomics J 9:347-353, 2009
-
(2009)
Pharmacogenomics J
, vol.9
, pp. 347-353
-
-
Caronia, D.1
Patiño-García, A.2
Milne, R.L.3
-
55
-
-
33947590154
-
Cisplatin-induced long-term hearing impairment is associated with specific glutathione S-transferase genotypes in testicular cancer survivors
-
DOI 10.1200/JCO.2006.08.9599
-
Oldenburg J, Kraggerud SM, Cvancarova M, et al: Cisplatin-induced long-term hearing impairment is associated with specific glutathione s-transferase genotypes in testicular cancer survivors. J Clin Oncol 25:708-714, 2007 (Pubitemid 350002927)
-
(2007)
Journal of Clinical Oncology
, vol.25
, Issue.6
, pp. 708-714
-
-
Oldenburg, J.1
Kraggerud, S.M.2
Cvancarova, M.3
Lothe, R.A.4
Fossa, S.D.5
-
56
-
-
0037384555
-
Pharmacogenomic can give children safer medicines
-
Impicciatore M: Pharmacogenomic can give children safer medicines. Arch Dis Child 88:366, 2003
-
(2003)
Arch Dis Child
, vol.88
, pp. 366
-
-
Impicciatore, M.1
-
57
-
-
34249997024
-
Replicating genotype-phenotype associations
-
NCI-NHGRI Working Group on Replication in Association Studies
-
NCI-NHGRI Working Group on Replication in Association Studies, Chanock SJ, Manolio T, et al: Replicating genotype-phenotype associations. Nature 447:655-660, 2007
-
(2007)
Nature
, vol.447
, pp. 655-660
-
-
Chanock, S.J.1
Manolio, T.2
-
59
-
-
0022635031
-
Effects of mild and moderate hearing impairments on language, educational, and psychosocial behavior of children
-
Davis JM, Elfenbein J, Schum R, et al: Effects of mild and moderate hearing impairments on language, educational, and psychosocial behavior of children. J Speech Hear Disord 51:53-62, 1986 (Pubitemid 16165644)
-
(1986)
Journal of Speech and Hearing Disorders
, vol.51
, Issue.1
, pp. 53-62
-
-
Davis, J.M.1
Elfenbein, J.2
Schum, R.3
Bentler, R.A.4
-
60
-
-
0031667362
-
Children with minimal sensorineural hearing loss: Prevalence, educational performance, and functional status
-
DOI 10.1097/00003446-199810000-00001
-
Bess FH, Dodd-Murphy J, Parker RA: Children with minimal sensorineural hearing loss: Prevalence, educational performance, and functional status. Ear Hear 19:339-354, 1998 (Pubitemid 28465218)
-
(1998)
Ear and Hearing
, vol.19
, Issue.5
, pp. 339-354
-
-
Bess, F.H.1
Dodd-Murphy, J.2
Parker, R.A.3
-
61
-
-
0036150216
-
Recognition of low-pass-filtered consonants in noise with normal and impaired high-frequency hearing
-
DOI 10.1121/1.1427357
-
Horwitz AR, Dubno JR, Ahlstrom JB: Recognition of low-pass-filtered consonants in noise with normal and impaired high-frequency hearing. J Acoust Soc Am 111:409-416, 2002 (Pubitemid 34093335)
-
(2002)
Journal of the Acoustical Society of America
, vol.111
, Issue.1 I
, pp. 409-416
-
-
Horwitz, A.R.1
Dubno, J.R.2
Ahlstrom, J.B.3
-
62
-
-
2342603018
-
The Importance of High-Frequency Audibility in the Speech and Language Development of Children with Hearing Loss
-
DOI 10.1001/archotol.130.5.556
-
Stelmachowicz PG, Pittman AL, Hoover BM, et al: The importance of high-frequency audibility in the speech and language development of children with hearing loss. Arch Otolaryngol Head Neck Surg 130:556-562, 2004 (Pubitemid 38609664)
-
(2004)
Archives of Otolaryngology - Head and Neck Surgery
, vol.130
, Issue.5
, pp. 556-562
-
-
Stelmachowicz, P.G.1
Pittman, A.L.2
Hoover, B.M.3
Lewis, D.E.4
Moeller, M.P.5
-
63
-
-
36049033016
-
Hearing loss, quality of life, and academic problems in long-term neuroblastoma survivors: A report from the Children's Oncology Group
-
DOI 10.1542/peds.2007-0178
-
Gurney JG, Tersak JM, Ness KK, et al: Hearing loss, quality of life, and academic problems in long-term neuroblastoma survivors: A report from the Children's Oncology Group. Pediatrics 120: e1229-e1236, 2007 (Pubitemid 350085519)
-
(2007)
Pediatrics
, vol.120
, Issue.5
-
-
Gurney, J.G.1
Tersak, J.M.2
Ness, K.K.3
Landier, W.4
Matthay, K.K.5
Schmidt, M.L.6
-
64
-
-
77950481805
-
Critical need for international consensus on ototoxicity assessment criteria
-
Neuwelt EA, Brock P: Critical need for international consensus on ototoxicity assessment criteria. J Clin Oncol 28:1630-1632, 2010
-
(2010)
J Clin Oncol
, vol.28
, pp. 1630-1632
-
-
Neuwelt, E.A.1
Brock, P.2
-
65
-
-
84907039716
-
Developmental factors in speech recognition
-
Boothroyd A: Developmental factors in speech recognition. Int J Audiol 9:30-38, 1970
-
(1970)
Int J Audiol
, vol.9
, pp. 30-38
-
-
Boothroyd, A.1
-
66
-
-
0030814593
-
Normal and hearing-impaired word recognition scores for monosyllabic words in quiet and noise
-
Beattie RC, Barr T, Roup C: Normal and hearing-impaired word recognition scores for monosyllabic words in quiet and noise. Br J Audiol 31:153-164, 1997 (Pubitemid 27367648)
-
(1997)
British Journal of Audiology
, vol.31
, Issue.3
, pp. 153-164
-
-
Beattie, R.C.1
Barr, T.2
Roup, C.3
-
67
-
-
0027263938
-
Speech recognition in noise by children with minimal degrees of sensorineural hearing loss
-
Crandell CC: Speech recognition in noise by children with minimal degrees of sensorineural hearing loss. Ear Hear 14:210-216, 1993
-
(1993)
Ear Hear
, vol.14
, pp. 210-216
-
-
Crandell, C.C.1
-
68
-
-
0018166160
-
Room acoustics effects on monosyllabic word discrimination ability for normal and hearing-impaired children
-
Finitzo-Hieber T, Tillman TW: Room acoustics effects on monosyllabic word discrimination ability for normal and hearing-impaired children. J Speech Hear Res 21:440-458, 1978 (Pubitemid 9028171)
-
(1978)
Journal of Speech and Hearing Research
, vol.21
, Issue.3
, pp. 440-458
-
-
Finitzo-Hieber, T.1
Tillman, T.W.2
-
69
-
-
34548142624
-
Toxicity prevention with amifostine in pediatric osteosarcoma patients treated with cisplatin and doxorubicin
-
DOI 10.1080/08880010701451244, PII 781393656
-
Gallegos-Castorena S, Martínez-Avalos A, Mohar-Betancourt A, et al: Toxicity prevention with amifostine in pediatric osteosarcoma patients treated with cisplatin and doxorubicin. Pediatr Hematol Oncol 24:403-408, 2007 (Pubitemid 47301148)
-
(2007)
Pediatric Hematology and Oncology
, vol.24
, Issue.6
, pp. 403-408
-
-
Gallegos-Castorena, S.1
Martinez-Avalos, A.2
Mohar-Betancourt, A.3
Guerrero-Avendano, G.4
Zapata-Tarres, M.5
Medina-Sanson, A.6
-
70
-
-
9344256710
-
Amifostine for children with medulloblastoma treated with cisplatin-based chemotherapy
-
DOI 10.1002/pbc.20132
-
Fisher MJ, Lange BJ, Needle MN, et al: Amifostine for children with medulloblastoma treated with cisplatin-based chemotherapy. Pediatr Blood Cancer 43:780-784, 2004 (Pubitemid 39557716)
-
(2004)
Pediatric Blood and Cancer
, vol.43
, Issue.7
, pp. 780-784
-
-
Fisher, M.J.1
Lange, B.J.2
Needle, M.N.3
Janss, A.J.4
Shu, H.-K.G.5
Adamson, P.C.6
Phillips, P.C.7
-
71
-
-
49249083377
-
Amifostine protects against cisplatin-induced ototoxicity in children with average-risk medulloblastoma
-
Fouladi M, Chintagumpala M, Ashley D, et al: Amifostine protects against cisplatin-induced ototoxicity in children with average-risk medulloblastoma. J Clin Oncol 26:3749-3755, 2008
-
(2008)
J Clin Oncol
, vol.26
, pp. 3749-3755
-
-
Fouladi, M.1
Chintagumpala, M.2
Ashley, D.3
-
73
-
-
77950484560
-
Practical grading system for evaluating cisplatin ototoxicity in children
-
Chang KW, Chinosornvatana N: Practical grading system for evaluating cisplatin ototoxicity in children. J Clin Oncol 28:1788-1795, 2010
-
(2010)
J Clin Oncol
, vol.28
, pp. 1788-1795
-
-
Chang, K.W.1
Chinosornvatana, N.2
-
74
-
-
0032947768
-
Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin
-
Go RS, Adjei AA: Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin. J Clin Oncol 17:409-422, 1999 (Pubitemid 29022420)
-
(1999)
Journal of Clinical Oncology
, vol.17
, Issue.1
, pp. 409-422
-
-
Go, R.S.1
Adjei, A.A.2
-
75
-
-
34547100275
-
The resurgence of platinum-based cancer chemotherapy
-
Kelland L: The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer 7:573-584, 2007
-
(2007)
Nat Rev Cancer
, vol.7
, pp. 573-584
-
-
Kelland, L.1
-
76
-
-
0034944185
-
L-N-acetyl-cysteine protection against cisplatin-induced auditory neuronal and hair cell toxicity
-
Feghali JG, Liu W, Van De Water TR: L-n-acetyl-cysteine protection against cisplatin-induced auditory neuronal and hair cell toxicity. Laryngoscope 111:1147-1155, 2001 (Pubitemid 32625400)
-
(2001)
Laryngoscope
, vol.111
, Issue.7
, pp. 1147-1155
-
-
Feghali, J.G.1
Liu, W.2
Van De, W.T.R.3
-
77
-
-
8544249184
-
Prevention of cisplatin ototoxicity using transtympanic N-acetylcysteine and lactate
-
DOI 10.1097/00129492-200411000-00009
-
Choe WT, Chinosornvatana N, Chang KW: Prevention of cisplatin ototoxicity using transtympanic N-acetylcysteine and lactate. Otol Neurotol 25:910-915, 2004 (Pubitemid 39491671)
-
(2004)
Otology and Neurotology
, vol.25
, Issue.6
, pp. 910-915
-
-
Choe, W.-T.1
Chinosornvatana, N.2
Chang, K.W.3
-
78
-
-
43749101881
-
Effect of N-acetylcysteine route of administration on chemoprotection against cisplatin-induced toxicity in rat models
-
DOI 10.1007/s00280-007-0597-2
-
Dickey DT, Muldoon LL, Doolittle ND, et al: Effect of N-acetylcysteine route of administration on chemoprotection against cisplatin-induced toxicity in rat models. Cancer Chemother Pharmacol 62:235-241, 2008 (Pubitemid 351692079)
-
(2008)
Cancer Chemotherapy and Pharmacology
, vol.62
, Issue.2
, pp. 235-241
-
-
Dickey, D.T.1
Muldoon, L.L.2
Doolittle, N.D.3
Peterson, D.R.4
Kraemer, D.F.5
Neuwelt, E.A.6
-
79
-
-
2942748653
-
Protective effects of alpha-tocopherol and tiopronin against cisplatin-induced ototoxicity
-
DOI 10.1080/00016480410016559
-
Fetoni AR, Sergi B, Ferraresi A, et al: Protective effects of alpha-tocopherol and tiopronin against cisplatin-induced ototoxicity. Acta Otolaryngol 124: 421-426, 2004 (Pubitemid 38797598)
-
(2004)
Acta Oto-Laryngologica
, vol.124
, Issue.4
, pp. 421-426
-
-
Fetoni, A.R.1
Sergi, B.2
Ferraresi, A.3
Paludetti, G.4
Troiani, D.5
-
80
-
-
1642338446
-
Vitamin E Reduces Cisplatin Ototoxicity
-
DOI 10.1097/00005537-200403000-00028
-
Kalkanis JG, Whitworth C, Rybak LP: Vitamin E reduces cisplatin ototoxicity. Laryngoscope 114: 538-542, 2004 (Pubitemid 38391921)
-
(2004)
Laryngoscope
, vol.114
, Issue.3
, pp. 538-542
-
-
Kalkanis, J.G.1
Whitworth, C.2
Rybak, L.P.3
-
81
-
-
0032938438
-
Dose dependent protection by lipoic acid against cisplatin-induced ototoxicity in rats: Antioxidant defense system
-
DOI 10.1093/toxsci/47.2.195
-
Rybak LP, Husain K, Whitworth C, et al: Dose dependent protection by lipoic acid against cisplatin-induced ototoxicity in rats: Antioxidant defense system. Toxicol Sci 47:195-202, 1999 (Pubitemid 29214827)
-
(1999)
Toxicological Sciences
, vol.47
, Issue.2
, pp. 195-202
-
-
Rybak, L.P.1
Husain, K.2
Whitworth, C.3
Somani, S.M.4
-
82
-
-
0032694345
-
Application of antioxidants and other agents to prevent cisplatin ototoxicity
-
DOI 10.1097/00005537-199911000-00003
-
Rybak LP, Whitworth C, Somani S: Application of antioxidants and other agents to prevent cisplatin ototoxicity. Laryngoscope 109:1740-1744, 1999 (Pubitemid 29533912)
-
(1999)
Laryngoscope
, vol.109
, Issue.11
, pp. 1740-1744
-
-
Rybak, L.P.1
Whitworth, C.2
Somani, S.3
-
83
-
-
58149395091
-
Short interfering RNA against transient receptor potential vanilloid 1 attenuates cisplatin-induced hearing loss in the rat
-
Mukherjea D, Jajoo S, Whitworth C, et al: Short interfering RNA against transient receptor potential vanilloid 1 attenuates cisplatin-induced hearing loss in the rat. J Neurosci 28:13056-13065, 2008
-
(2008)
J Neurosci
, vol.28
, pp. 13056-13065
-
-
Mukherjea, D.1
Jajoo, S.2
Whitworth, C.3
-
84
-
-
0030697447
-
Comparison of five agents in protecting the cochlea against the ototoxic effects of cisplatin in the hamster
-
Kaltenbach JA, Church MW, Blakley BW, et al: Comparison of five agents in protecting the cochlea against the ototoxic effects of cisplatin in the hamster. Otolaryngol Head Neck Surg 117:493-500, 1997 (Pubitemid 27508141)
-
(1997)
Otolaryngology - Head and Neck Surgery
, vol.117
, Issue.5
, pp. 493-500
-
-
Kaltenbach, J.A.1
Church, M.W.2
Blakley, B.W.3
McCaslin, D.L.4
Burgio, D.L.5
-
85
-
-
0037966412
-
Local application of sodium thiosulfate prevents cisplatin-induced hearing loss in the guinea pig
-
DOI 10.1016/S0028-3908(03)00194-1
-
Wang J, Lloyd Faulconbridge RV, Fetoni A, et al: Local application of sodium thiosulfate prevents cisplatin-induced hearing loss in the guinea pig. Neuropharmacology 45:380-393, 2003 (Pubitemid 36836134)
-
(2003)
Neuropharmacology
, vol.45
, Issue.3
, pp. 380-393
-
-
Wang, J.1
Lloyd, F.R.V.2
Fetoni, A.3
Guitton, M.J.4
Pujol, R.5
Puel, J.L.6
-
86
-
-
0029125122
-
The comparative effects of sodium thiosulfate, diethyldithiocarbamate, fosfomycin and WR-2721 on ameliorating cisplatin-induced ototoxicity
-
Church MW, Kaltenbach JA, Blakley BW, et al: The comparative effects of sodium thiosulfate, diethyldithiocarbamate, fosfomycin and WR-2721 on ameliorating cisplatin-induced ototoxicity. Hear Res 86:195-203, 1995
-
(1995)
Hear Res
, vol.86
, pp. 195-203
-
-
Church, M.W.1
Kaltenbach, J.A.2
Blakley, B.W.3
-
87
-
-
0033959645
-
Delayed administration of sodium thiosulfate in animal models reduces platinum ototoxicity without reduction of antitumor activity
-
Muldoon LL, Pagel MA, Kroll RA, et al: Delayed administration of sodium thiosulfate in animal models reduces platinum ototoxicity without reduction of antitumor activity. Clin Cancer Res 6:309-315, 2000 (Pubitemid 30065007)
-
(2000)
Clinical Cancer Research
, vol.6
, Issue.1
, pp. 309-315
-
-
Muldoon, L.L.1
Pagel, M.A.2
Kroll, R.A.3
Brummett, R.E.4
Doolittle, N.D.5
Zuhowski, E.G.6
Egorin, M.J.7
Neuwelt, E.A.8
-
88
-
-
0036091647
-
Salicylate protects hearing and kidney function from cisplatin toxicity without compromising its oncolytic action
-
DOI 10.1038/labinvest.3780453
-
Li G, Sha SH, Zotova E, et al: Salicylate protects hearing and kidney function from cisplatin toxicity without compromising its oncolytic action. Lab Invest 82:585-596, 2002 (Pubitemid 34522371)
-
(2002)
Laboratory Investigation
, vol.82
, Issue.5
, pp. 585-596
-
-
Li, G.1
Sha, S.-H.2
Zotova, E.3
Arezzo, J.4
Van De, W.T.R.5
Schacht, J.6
-
89
-
-
13844266756
-
Reduction of acute cisplatin ototoxicity and nephrotoxicity in rats by oral administration of allopurinol and ebselen
-
DOI 10.1016/j.heares.2004.08.002
-
Lynch ED, Gu R, Pierce C, et al: Reduction of acute cisplatin ototoxicity and nephrotoxicity in rats by oral administration of allopurinol and ebselen. Hear Res 201:81-89, 2005 (Pubitemid 40255547)
-
(2005)
Hearing Research
, vol.201
, Issue.1-2
, pp. 81-89
-
-
Lynch, E.D.1
Gu, R.2
Pierce, C.3
Kil, J.4
-
90
-
-
0030561543
-
D-Methionine provides excellent protection from cisplatin ototoxicity in the rat
-
DOI 10.1016/S0378-5955(96)00152-9, PII S0378595596001529
-
Campbell KC, Rybak LP, Meech RP, et al: D-methionine provides excellent protection from cisplatin ototoxicity in the rat. Hear Res 102:90-98, 1996 (Pubitemid 26388984)
-
(1996)
Hearing Research
, vol.102
, Issue.1-2
, pp. 90-98
-
-
Campbell, K.C.M.1
Rybak, L.P.2
Meech, R.P.3
Hughes, L.4
-
91
-
-
0842284222
-
Assessment of the Protective Effects of Amifostine against Cisplatin-Induced Toxicity
-
Hussain AE, Blakley BW, Nicolas M, et al: Assessment of the protective effects of amifostine against cisplatin-induced toxicity. J Otolaryngol 32: 294-297, 2003 (Pubitemid 38175959)
-
(2003)
Journal of Otolaryngology
, vol.32
, Issue.5
, pp. 294-297
-
-
Hussain, A.E.1
Blakley, B.W.2
Nicolas, M.3
Balderston, J.4
-
92
-
-
59849098027
-
Cisplatin-induced ototoxicity: Effect of intratympanic dexamethasone injections
-
Hill GW, Morest DK, Parham K: Cisplatin-induced ototoxicity: Effect of intratympanic dexamethasone injections. Otol Neurotol 29:1005-1011, 2008
-
(2008)
Otol Neurotol
, vol.29
, pp. 1005-1011
-
-
Hill, G.W.1
Morest, D.K.2
Parham, K.3
-
93
-
-
75749128927
-
Ototoxic drugs: Difference in sensitivity between mice and guinea pigs
-
Poirrier AL, Van den Ackerveken P, Kim TS, et al: Ototoxic drugs: Difference in sensitivity between mice and guinea pigs. Toxicol Lett 193:41-49, 2010
-
(2010)
Toxicol Lett
, vol.193
, pp. 41-49
-
-
Poirrier, A.L.1
Van Den Ackerveken, P.2
Kim, T.S.3
-
95
-
-
85027922952
-
The protective effects of intratympanic dexamethasone and vitamin E on cisplatin-induced ototoxicity are demonstrated in rats
-
Paksoy M, Ayduran E, Sanli A, et al: The protective effects of intratympanic dexamethasone and vitamin E on cisplatin-induced ototoxicity are demonstrated in rats. Med Oncol 28:615-621, 2011
-
(2011)
Med Oncol
, vol.28
, pp. 615-621
-
-
Paksoy, M.1
Ayduran, E.2
Sanli, A.3
-
96
-
-
2342441227
-
Round window application of D-methionine, sodium thiosulfate, brain-derived neurotrophic factor, and fibroblast growth factor-2 in cisplatin-induced ototoxicity
-
DOI 10.1097/00129492-200401000-00007
-
Wimmer C, Mees K, Stumpf P, et al: Round window application of D-methionine, sodium thiosulfate, brain-derived neurotrophic factor, and fibroblast growth factor-2 in cisplatin-induced ototoxicity. Otol Neurotol 25:33-40, 2004 (Pubitemid 39077568)
-
(2004)
Otology and Neurotology
, vol.25
, Issue.1
, pp. 33-40
-
-
Wimmer, C.1
Mees, K.2
Stumpf, P.3
Welsch, U.4
Reichel, O.5
Suckfull, M.6
-
97
-
-
77954754161
-
Role of the copper transporter, CTR1, in platinum-induced ototoxicity
-
More SS, Akil O, Ianculescu AG, et al: Role of the copper transporter, CTR1, in platinum-induced ototoxicity. J Neurosci 30:9500-9509, 2010
-
(2010)
J Neurosci
, vol.30
, pp. 9500-9509
-
-
More, S.S.1
Akil, O.2
Ianculescu, A.G.3
-
98
-
-
0036598487
-
Round window application of D-methionine provides complete cisplatin otoprotection
-
DOI 10.1067/mhn.2002.125299
-
Korver KD, Rybak LP, Whitworth C, et al: Round window application of D-methionine provides complete cisplatin otoprotection. Otolaryngol Head Neck Surg 126:683-689, 2002 (Pubitemid 41115249)
-
(2002)
Otolaryngology - Head and Neck Surgery
, vol.126
, Issue.6
, pp. 683-689
-
-
Korver, K.D.1
Rybak, L.P.2
Whitworth, C.3
Campbell, K.M.4
-
99
-
-
33947275322
-
Prevention of noise- and drug-induced hearing loss with d-methionine
-
DOI 10.1016/j.heares.2006.11.012, PII S0378595506003315, Pharmacological Strategies for Prevention and Treatment of Hearing Loss and Tinnitus
-
Campbell KC, Meech RP, Klemens JJ, et al: Prevention of noise- and drug-induced hearing loss with D-methionine. Hear Res 226:92-103, 2007 (Pubitemid 46428036)
-
(2007)
Hearing Research
, vol.226
, Issue.1-2
, pp. 92-103
-
-
Campbell, K.C.M.1
Meech, R.P.2
Klemens, J.J.3
Gerberi, M.T.4
Dyrstad, S.S.W.5
Larsen, D.L.6
Mitchell, D.L.7
El-Azizi, M.8
Verhulst, S.J.9
Hughes, L.F.10
-
100
-
-
38949097507
-
Sodium thiosulfate administered six hours after cisplatin does not compromise antineuroblastoma activity
-
DOI 10.1158/1078-0432.CCR-06-2289
-
Harned TM, Kalous O, Neuwelt A, et al: Sodium thiosulfate administered six hours after cisplatin does not compromise antineuroblastoma activity. Clin Cancer Res 14:533-540, 2008 (Pubitemid 351226123)
-
(2008)
Clinical Cancer Research
, vol.14
, Issue.2
, pp. 533-540
-
-
Harned, T.M.1
Kalous, O.2
Neuwelt, A.3
Loera, J.4
Ji, L.5
Iovine, P.6
Sposto, R.7
Neuwelt, E.A.8
Reynolds, C.P.9
-
101
-
-
2142750157
-
Bone Marrow Chemoprotection without Compromise of Chemotherapy Efficacy in a Rat Brain Tumor Model
-
DOI 10.1124/jpet.103.063347
-
Neuwelt EA, Pagel MA, Kraemer DF, et al: Bone marrow chemoprotection without compromise of chemotherapy efficacy in a rat brain tumor model. J Pharmacol Exp Ther 309:594-599, 2004 (Pubitemid 38542612)
-
(2004)
Journal of Pharmacology and Experimental Therapeutics
, vol.309
, Issue.2
, pp. 594-599
-
-
Neuwelt, E.A.1
Pagel, M.A.2
Kraemer, D.F.3
Peterson, D.R.4
Muldoon, L.L.5
-
102
-
-
73149120511
-
Amifostine does not prevent platinum-induced hearing loss associated with the treatment of children with hepatoblastoma: A report of the Intergroup Hepatoblastoma Study P9645 as a part of the Children's Oncology Group
-
Katzenstein HM, Chang KW, Krailo M, et al: Amifostine does not prevent platinum-induced hearing loss associated with the treatment of children with hepatoblastoma: A report of the Intergroup Hepatoblastoma Study P9645 as a part of the Children's Oncology Group. Cancer 115:5828-5835, 2009
-
(2009)
Cancer
, vol.115
, pp. 5828-5835
-
-
Katzenstein, H.M.1
Chang, K.W.2
Krailo, M.3
-
104
-
-
34548481762
-
Ototoxicity in a randomized phase III trial of intra-arterial compared with intravenous cisplatin chemoradiation in patients with locally advanced head and neck cancer
-
DOI 10.1200/JCO.2006.08.9540
-
Zuur CL, Simis YJ, Lansdaal PE, et al: Ototoxicity in a randomized phase III trial of intra-arterial compared with intravenous cisplatin chemoradiation in patients with locally advanced head and neck cancer. J Clin Oncol 25:3759-3765, 2007 (Pubitemid 47372618)
-
(2007)
Journal of Clinical Oncology
, vol.25
, Issue.24
, pp. 3759-3765
-
-
Zuur, C.L.1
Simis, Y.J.2
Lansdaal, P.E.3
Hart, A.A.4
Schornagel, J.H.5
Dreschler, W.A.6
Rasch, C.R.7
Balm, A.J.8
-
105
-
-
58149335531
-
American Society of Clinical Oncology 2008 clinical practice guideline update: Use of chemotherapy and radiation therapy protectants
-
Hensley ML, Hagerty KL, Kewalramani T, et al: American Society of Clinical Oncology 2008 clinical practice guideline update: Use of chemotherapy and radiation therapy protectants. J Clin Oncol 27: 127-145, 2009
-
(2009)
J Clin Oncol
, vol.27
, pp. 127-145
-
-
Hensley, M.L.1
Hagerty, K.L.2
Kewalramani, T.3
-
106
-
-
0034482931
-
Evaluation of D-methionine as a cytoprotectant in cisplatin treatment of an animal model for ovarian cancer
-
Cloven NG, Re A, McHale MT, et al: Evaluation of D-methionine as a cytoprotectant in cisplatin treatment of an animal model for ovarian cancer. Anticancer Res 20:4205-4209, 2000 (Pubitemid 32141765)
-
(2000)
Anticancer Research
, vol.20
, Issue.6 B
, pp. 4205-4209
-
-
Cloven, N.G.1
Re, A.2
McHale, M.T.3
Burger, R.A.4
DiSaia, P.J.5
Scott, R.G.6
Campbell, K.C.M.7
Fan, H.8
-
108
-
-
18844383751
-
Combined oral delivery of ebselen and allopurinol reduces multiple cisplatin toxicities in rat breast and ovarian cancer models while enhancing anti-tumor activity
-
DOI 10.1097/00001813-200506000-00013
-
Lynch ED, Gu R, Pierce C, et al: Combined oral delivery of ebselen and allopurinol reduces multiple cisplatin toxicities in rat breast and ovarian cancer models while enhancing anti-tumor activity. Anticancer Drugs 16:569-579, 2005 (Pubitemid 40685742)
-
(2005)
Anti-Cancer Drugs
, vol.16
, Issue.5
, pp. 569-579
-
-
Lynch, E.D.1
Gu, R.2
Pierce, C.3
Kil, J.4
-
109
-
-
46049100805
-
Superiority, equivalence, and non-inferiority trials
-
Lesaffre E: Superiority, equivalence, and non-inferiority trials. Bull NYU Hosp Jt Dis 66:150-154, 2008
-
(2008)
Bull NYU Hosp Jt Dis
, vol.66
, pp. 150-154
-
-
Lesaffre, E.1
-
110
-
-
7044260303
-
Predicting cisplatin ototoxicity in children: The influence of age and the cumulative dose
-
DOI 10.1016/j.ejca.2003.08.009, PII S0959804903007287
-
Li Y, Womer RB, Silber JH: Predicting cisplatin ototoxicity in children: The influence of age and the cumulative dose. Eur J Cancer 40:2445-2451, 2004 (Pubitemid 39424959)
-
(2004)
European Journal of Cancer
, vol.40
, Issue.16
, pp. 2445-2451
-
-
Li, Y.1
Womer, R.B.2
Silber, J.H.3
-
111
-
-
82155166492
-
Clinically accurate assessment and grading of ototoxicity
-
Chang KW: Clinically accurate assessment and grading of ototoxicity. Laryngoscope 121:2649-2657, 2011
-
(2011)
Laryngoscope
, vol.121
, pp. 2649-2657
-
-
Chang, K.W.1
|